Viemed Healthcare, Inc. Q3 2025 Earnings Recap

VMD Q3 2025 November 8, 2025

Get alerts when VMD reports next quarter

Viemed Healthcare delivered a robust third quarter in 2025, marked by significant growth across its diversified service lines and successful integration of the Lehan's Medical Equipment acquisition.

Earnings Per Share Beat

$0.09 vs $0.09 est.

+0.0% surprise

Revenue Miss

71914000 vs 77700000 est.

-7.4% surprise

Market Reaction

1-Day +0.0%

5-Day +0.63%

30-Day +6.12%

See VMD alongside your other holdings

Add to your portfolio — free

Key Takeaways

Ventilation revenue achieved double-digit growth year-over-year, reflecting sustained demand and strategic positioning.
New sleep patient starts surged 96% year-over-year, with resupply population growth surpassing the PAP therapy rental base for the first time.
Integration of Lehan's expanded Viemed's employee base to 1,386 and facilitated entry into new markets and service offerings, including maternity health.
The Healthcare Staffing division showed resilience, contributing to operational synergies and continued growth.
Strategic execution positions Viemed for sustainable growth, enhancing its reputation as a trusted leader in home-based healthcare.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit VMD on AllInvestView.

Next Q1 2026